Redefining nonmeasurable multiple myeloma using mass spectrometry

Author
Giles, Hannah V
Cook, Mark A
Drayson, Mark Trehane
Cook, Gordon
Wright, Nicola Jane
North, Simon John
Harding, Stephen
Cairns, David A
Hockaday, Anna
Kaiser, Martin F
Affiliation
University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Bristol Myers Squibb; St James's Institute of Oncology; University of Leeds; The Binding Site Ltd; Royal Marsden Hospital; Perlmutter Cancer Center; NYU Langone Health Care; Newcastle University; Newcastle Upon Tyne Hospitals NHS Foundation Trust
Publication date
2022-02-10
Subject
Oncology. Pathology.
Haematology

Metadata
Show full item record
Abstract
No abstract available
Citation
Giles HV, Cook MA, Drayson MT, Cook G, Wright NJ, North SJ, Harding S, Cairns DA, Hockaday A, Kaiser MF, Moss P, Davies FE, Morgan GJ, Jackson G, Pratt G. Redefining nonmeasurable multiple myeloma using mass spectrometry. Blood. 2022 Feb 10;139(6):946-950. doi: 10.1182/blood.2021013794.
Type
Correspondence
Handle
http://hdl.handle.net/20.500.14200/6759
Additional Links
https://ashpublications.org/blood
DOI
10.1182/blood.2021013794
PMID
34871382
Journal
Blood
Publisher
Elsevier
Collections